have reported the initial clinical experience with Gd-EOB-DTPA in children [3, 4, 7] . A recent publication discusses initial experience with gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI, a contrast agent with similar hepatobiliary affinity [8] . However, the hepatobiliary excretion of Gd-BOPTA is lower (3-5%) compared to Gd-EOB-DTPA (as much as 50%); allowing for 1) a lower dose of Gd-EOB-DTPA; 2) earlier imaging of the hepatobiliary phase (i.e.; 10-20 minutes with Gd-EOB-DTPA compared to 45-60-minute delay with Gd-BOPTA); and 3) shorter table time studies [9] . Additionally, the largest study to date evaluating Gd-EOB-DTPA in children was based on a single reviewer perceived diagnostic confidence [7] . Our objective was to investigate the inter-reader agreement and perceived utility of Gd-EOB-DTPA enhanced MRI in the evaluation of liver lesions in children.
Introduction
Magnetic resonance imaging (MRI) is the modality of choice for imaging the liver and biliary tract in children, virtually replacing CT and ERCP [1] . Gadoxetate disodium (Gd-EOB-DTPA, Eovist, Bayer HealthCare Pharmaceuticals, Wayne, NJ) is a relatively new hepatocyte specific MR contrast agent useful for detecting and characterizing liver lesions. This agent highlights functioning hepatocyte-containing lesions and improves the depiction of lesions that lack functioning hepatocytes. Additionally, the same imaging techniques can be used for assessment of hepatocellular function and functional evaluation of the biliary tract [2] . The vast majority of clinical experience with this agent is in adults, however, increasing use among children is being reported [3, 4] . In children, Gd-EOB-DTPA enhanced MRI has the same potential to improve characterization of liver lesions [5] [6] [7] . Only a few original publications injector at a dose of 0.1ml/kg (0.025 m mol/kg) of body weight with a flow rate of 1ml/sec, followed by injection of 5-10mL of sterile saline weighted with fat saturation before the administration of intravenous Gd-EOB-DTPA. The contrast was administered using a power hepatobiliary phase utility scores were summarized and interreader variability was assessed using weighted kappa coefficient. The following value guidelines were followed in interpreting the kappa statistic: slight agreement: 0.00-0.20; fair agreement: 0.21-0.40; moderate agreement: 0.41-0.60; substantial agreement: 0.61-0.80; and almost perfect agreement: 0.80-1.00 [10] . All statistics were calculated using publicly available statistical software (Vassar Stats: Statistical Computation Website) [11] .
Results
Twenty-two patients, meeting our inclusion criteria, (17 male, 5 female) ages 4 months -19 years (median: 9 years; 8 patients younger than 7 years and 14 patients 8 years of age and older) underwent Gd-EOB-DTPA-MRI for the evaluation of liver lesions during the study period. Fifteen patients (68%) underwent imaging in a 1.5 Tesla magnet while the remaining 7 (32%) underwent imaging in a 3 Tesla magnet. Of the 22 patients with liver lesions, 21 underwent Gd-EOB-DTPA-MRI for further evaluation of lesions identified by a different imaging study (11 from CT, 8 from ultrasound and 2 from non-dedicated MRI); while the remaining patients had a diagnosis of Alagille syndrome and underwent Gd-EOB-DTPA-MRI as screening for hepatocellular carcinoma because of the inherent increased risk. Seven of the 22 patients (31%) had a past medical history of cancer including neuroblastoma (n = 3), hepatoblastoma (n = 1), medulloblastoma (n = 1), leukemia (n = 1), and granulosa cell tumor (n = 1). The final diagnosis of the lesions was: focal nodular hyperplasia-FNH-, FNH-like, or adenoma (10), hepatoblastoma (3), Abscesses (2), regenerative nodules (3), hemangioma (2), focal fatty infiltration (1) and coagulative necrosis (1) . Final imaging and clinical diagnoses as well as follow up data are summarized in table 2.
solution. Dynamic axial contrast enhanced volumetric T1 weighted GRE images were obtained after Gd-EOB-DTPA administration in the axial plane in the arterial (10 seconds), portal-venous (45-55 seconds) and 3 minutes delayed venous phases. Axial and coronal fat saturated single shot fast spine echo (SSFSE) images, axial T2 weighted with fat saturation, axial diffusion weighted images and coronal balanced steady-state free precession without fat saturation images were obtained. Subsequently, axial and coronal T1 weighted GRE with fat saturation images during hepatobiliary phase (at least 20-minutes post-injection) were also performed. The typical imaging protocol is summarized in table 1.
Image analysis
Two pediatric radiologists (R1 and R2) with 15 years and 14 years of experience, respectively, independently reviewed anonymized images including dynamic T1-weighted post contrast images for each lesion under investigation. The two reviewers were blinded to the clinical data, but were disclosed gender and age of each subject. Each reviewer assigned a diagnosis after reviewing the initial images (T1, T2 and post contrast arterial, portal-venous and venous phase imaging). Subsequently, during the same session, additional images during the hepatobiliary phase were shown and the reviewers were asked to confirm their initial diagnosis and to stratify the hepatobiliary images as a score of: 1) High utility: allows for definitive diagnosis or change the differential diagnosis; 2) Potential utility: adds diagnostic certainty; 3) No utility: final diagnosis was reached before hepatobiliary phase images.
Statistical analysis
Descriptive analysis of patients' demographics, study indications, imaging findings and final clinical diagnosis was performed. The At biopsy this was found to represent focal irregular, severe fibrosis in the setting of multilobular biliary cirrhosis resulting from cystic fibrosis.
MR are useful or at least potentially useful in a great majority (82%) of cases. In the remaining 18% (4/22) cases both reviewers agreed that hepatobiliary phase images were of no utility.
Discussion
The present study found almost perfect agreement between readers in diagnosing the liver lesions on liver MRI; which included Gd-EOB-DTPA-enhanced images. This highlights the excellent performance of contrast enhanced MR imaging in characterizing liver lesions, a well-established practice supported by literature in both adults [12] [13] [14] [15] [16] and children [1, 17, 18] before and after the advent of hepatobiliary contrast agents. Moreover, the results showed that hepatobiliary phase images are useful or at least potentially useful in a great majority (82%) of cases. These results are in accordance with previous studies that found significant improvement in the ability to characterize focal hepatic lesions with the addition of Gd-EOB-DTPA [7, [19] [20] [21] .
The results also showed moderate inter-reader agreement in terms of utility, which highlighted consensus regarding the type of lesions in which hepatobiliary phase images are most useful, namely FNH/ FNH-like lesions and regenerative nodules. These results concur with previous reports in both the adult [22] and pediatric [7, 8] literature.
High inter-reader agreement was seen regarding the type of lesions in which hepatobiliary contrast images are not useful, namely hepatoblastomas and hemangiomas. Regarding hepatoblastomas, the lack of perceived utility is most likely due to the limited differential diagnosis for large heterogeneous aggressive appearing enhancing hepatic masses seen in the 5 months-3-year age group. Additionally, the study was not designed to identify additional lesions or stage malignancies. However, a prior publication highlighted the usefulness of Gd-EOB-DTPA in defining the relationship of the primary tumor There was only one discrepancy between the reviewers' assigned diagnosis and the final clinical/pathological diagnosis. It was a case of a rim-enhancing lesion, which on biopsy proved to represent multiple discrete areas of coagulative necrosis with adjacent reactive changes of chronic inflammation and portal fibrosis. However, both reviewers characterized it as an abscess. In the final diagnosis of the focal liver lesions, there was interreader agreement in 20 of 22 cases with an almost perfect kappa coefficient (κ = 0.92). In the 2 cases in which the final diagnosis differed between the reviewers, one reviewer labeled the hepatic lesions as concerning and needing biopsy, while the second reviewer labeled the lesions as likely benign, regenerative nodule or FNH-like lesion, which would undergo imaging follow up. The former of the two patients underwent biopsy, which showed biliary cirrhosis with acute cholangitis (Figure 1) ; while the second patient underwent short term imaging follow up, which was reassuring for FNH-type lesion and was stable over the next 3 years.
In analysis of the added utility of Gd-EOB-DTPA, hepatobiliary phase images were given high utility scores in n = 10 cases (reviewer 1) and n = 6 cases (reviewer 2); while potential utility scores were given to n = 5 cases (reviewer 1) and n = 8 cases (reviewer 2) and no utility for n = 7 cases (reviewer 1) and n = 8 cases (reviewer 2). There was a moderate inter-reader agreement for the overall utility scores (weighted k = 0.48). However, there is high agreement regarding utility in cases of FNH/FNH-like lesions (Figure 2 ), regenerative nodules ( Figure 3 ) and focal fatty infiltration as well as high agreement in the lack of utility for venous malformation ("adult hemangioma") and hepatoblastoma cases. Overall, the hepatobiliary images were deemed useful (scores of 1 or 2) by both reviewers in 50% (11/22) cases and by at least one reviewer in additional 32% (7/22) cases. Consequently, the hepatobilliary phase images during Gd-EOB-DTPA enhanced- In these cases, the identification of FNH or regenerative nodules allows patients to return to their regular follow-up schedule.
Our study has several limitations mainly related to its retrospective nature, the small sample size and lack of pathologic correlate in a majority of the cases. Additionally, the utility scale is subjective and as such introduces a degree of "personal preference" into the analysis. However, the correlation among readers and the low number of patients that clinically required additional imaging followup or biopsy are encouraging findings that support the selective use of hepatobiliary contrast for the evaluation of focal liver lesions.
Our study showed excellent inter-reader agreement in characterizing liver lesions with Gd-EOB-DTPA, which is in keeping with a growing body of evidence suggesting an increased MR accuracy in the depiction and characterization of liver lesions using Gd-EOB-DTA [3, 6, 7, 29, 30] . The results also showed a perceived utility in a majority of cases with moderate inter-reader agreement, which means that there is potential for prospectively identifying whether hepatobiliary contrast is likely to be useful or not. Prospectively identifying the cases in which Gd-EOB-DTPA contrast is unlikely to be useful, is challenging, but attainable through careful scrutiny of clinical and laboratory data. Limiting the use of Gd-EOB-DTA to those studies with high pretest yield might prove a suitable approach to its incorporation in common clinical practice. Alternatively, Gd-EOB-DTPA could be used for characterization of focal liver lesions in all pediatric patients without sacrificing accuracy or diagnostic confidence.
Conclusion
Gd-EOB-DTPA enhanced MRI ranked as having high or potential utility in the majority of our cases with moderate inter-reader agreement and seems to demonstrate a promising role in improving the diagnosis and characterization of pediatric liver lesions.
with respect to hepatic vasculature and identifying intrahepatic lesions distant from the main tumor [4] . Hence, the previous publication does not contradict our findings but offers insight in other potential benefits of Gd-EOB-DTPA use beyond diagnosis [4] . Now, regarding hemangiomas, research has shown that some hemangiomas have a different enhancement pattern during Gd-DTPA-EOB than with purely extracellular gadolinium contrast, making it difficult to diagnose and in some cases this lesion may mimic hypervascular malignant tumors [23, 24] . The added difficulty is due to the lack of hepatocyte phase contrast uptake that results in relative hypointensity of the lesion, which might be misinterpreted as "washout", particularly in small lesions that enhanced homogeneously in early images [25] [26] [27] . However, hemangiomas are usually characterized with confidence before hepatobiliary phase imaging. Hence, the variable pattern of enhancement during hepatobiliary phase is of little use and does not add to the radiologist's diagnostic confidence [7] .
Differentiation between regenerating or dysplastic nodules and differentiated hepatocellular carcinoma (HCC) in the cirrhotic liver based on imaging alone can be challenging and at times impossible. However, lack of suspicious features on MRI might suffice to enroll the patient in long-term follow up to document stability over time. Hence, the additional information provided by Gd-EOB-DTPA has the potential to increase diagnostic confidence and in turn decrease the number of patients that require additional work-up, short term follow up and biopsies. In our sample, only few lesions required additional short term imaging (n = 4) or biopsy (n = 3); which creates a limitation for the study, but serves as further proof that MRI is clinically relevant in separating patients requiring additional work up and those that can be safely followed. The benefit might be even higher in a selected population with increased incidence of benign lesions; such as FNH-like lesions in cancer survivors or regenerative nodules in the setting of cirrhosis [28] . homogeneous enhancement, which is isointense to the rest of the liver on hepatobilliary phase image confirms the diagnosis of regenerative nodule.
